Advertisement
Advertisement
Zykadia

Zykadia

ceritinib

Manufacturer:

Novartis Pharma Stein
Information is sourced from publicly available references. The information is for educational purpose of healthcare professionals and we are not liable for any loss or damage.
Core Prescribing Info
Contents
Ceritinib
Indications/Uses
Patients w/ anaplastic lymphoma kinase +ve, locally advanced or metastatic NSCLC w/ or w/o metastases to the brain.
Dosage/Direction for Use
450 mg once daily. Max: 450 mg once daily.
Administration
Should be taken with food: Take at the same time each day. Swallow whole, do not chew/crush.
MIMS Class
Targeted Cancer Therapy
ATC Classification
L01ED02 - ceritinib ; Belongs to the class of anaplastic lymphoma kinase (ALK) inhibitors. Used in the treatment of cancer.
Presentation/Packing
Form
Zykadia cap 150 mg
Packing/Price
1's
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement